Researchers at the University of Oklahoma Health Sciences Center are investigating how the ketogenic diet affects patients with multiple sclerosis (MS). This dietary approach, which shifts the body’s primary fuel source from glucose to ketones, is being studied for its potential to reduce neuroinflammation and alleviate chronic fatigue, according to current clinical research trends in neurological nutrition.
How Ketosis May Protect the Central Nervous System
The ketogenic diet is a high-fat, low-carbohydrate regimen that forces the body into a metabolic state called ketosis. In this state, the liver converts fats into ketones, which cross the blood-brain barrier to provide an alternative energy source for neurons. For people with MS, this metabolic shift is significant because it may address mitochondrial dysfunction—a common issue where cells can’t produce energy efficiently.
According to research published in Frontiers in Neurology, ketones may act as signaling molecules that reduce the production of pro-inflammatory cytokines. By lowering systemic inflammation, the diet might slow the degradation of the myelin sheath, the protective coating around nerve fibers that is attacked by the immune system in MS patients. This process doesn’t cure the disease, but it aims to stabilize the environment surrounding the nerves to prevent further damage.
Targeting MS Fatigue and Cognitive Fog
One of the most debilitating symptoms of MS is profound fatigue, which doesn’t always improve with rest. Researchers are focusing on the ketogenic diet’s ability to stabilize blood sugar and improve cellular energy metabolism to combat this “brain fog.”
Preliminary evidence suggests that ketosis improves the efficiency of ATP production in the mitochondria. When the brain uses ketones instead of glucose, it may reduce oxidative stress. According to the National Multiple Sclerosis Society, while dietary changes aren’t a replacement for disease-modifying therapies (DMTs), supporting overall metabolic health can improve a patient’s quality of life and functional capacity.
Comparing Keto to Other MS Dietary Protocols
The ketogenic diet is one of several nutritional strategies used by MS patients, but it differs significantly in its mechanism and restrictiveness. While some diets focus on specific nutrients, keto focuses on metabolic state.
| Dietary Approach | Primary Focus | Core Mechanism |
|---|---|---|
| Ketogenic Diet | Ultra-low carb, high fat | Induces ketosis to reduce inflammation and fuel neurons. |
| Wahls Protocol | High nutrient density (leafy greens, organ meats) | Addresses micronutrient deficiencies to support mitochondrial health. |
| Swank Diet | Very low saturated fat | Aims to reduce inflammation by limiting saturated fats. |
Medical Risks and Necessary Precautions
A ketogenic diet isn’t safe for everyone, especially those with complex medical histories. Dr. Natalie Singh notes that the restrictive nature of keto can lead to nutrient deficiencies if not carefully managed by a healthcare provider.
Key risks associated with the diet include:
- Kidney Stress: Increased protein or ketone levels can strain the kidneys in patients with pre-existing renal issues.
- Dyslipidemia: Some patients experience a sharp rise in LDL (bad) cholesterol due to high saturated fat intake.
- The “Keto Flu”: Initial symptoms like nausea, headaches, and irritability can mimic MS flares, making it difficult to track disease progression without medical supervision.
Patients are advised to consult their neurologist before starting the diet, as some medications may need dosage adjustments when blood glucose levels drop significantly.
The Path Forward for MS Nutrition
The shift toward studying the ketogenic diet at institutions like OU Health reflects a broader move toward “precision nutrition” in neurology. Rather than a one-size-fits-all diet, doctors are looking for biomarkers to determine which patients will respond best to ketosis.
Future studies will likely focus on whether the ketogenic diet can synergize with existing disease-modifying therapies to not only stop new lesions from forming but to potentially aid in remyelination—the repair of the damaged myelin sheath. Until large-scale, peer-reviewed clinical trials provide definitive guidelines, the diet remains a complementary tool rather than a primary treatment.